ENTITY
InnoCare Pharma

InnoCare Pharma (9969 HK)

120
Analysis
Health Care • China
InnoCare Pharma is a commercial-stage biopharmaceutical company dedicated to discovering, developing, and commercializing drugs for cancer and autoimmune diseases. Its pipeline includes key products like orelabrutinib, tafasitamab, and ICP-332. The company was co-founded in 2015 and is headquartered in Beijing, China.
more
Company Event • 26 Oct 2026 16:00 • Upcoming
Add To Calendar

Q3 2026

Company Event • 25 Mar 2027 12:30 • Upcoming
Add To Calendar

Q4 2026

Company Event • 24 Aug 2026 20:30 • Latest

Q2 2026

Company Event • 23 Apr 2026 18:45 • Upcoming
Add To Calendar

Q1 2026

Company Event • 25 Mar 2026 20:30

Q4 2025

x